NIHR Alert: Platform trial rules out treatments for COVID-19, NIHR
Expert commentary is provided for a trial which found adding doxycycline, azithromycin or colchicine to usual care provides no benefit to people in the community with COVID-19. These data are useful as preventing ineffective antibiotic use is critical to reduce drug resistance.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
More News: Azithromycin | Colchicine | Colcrys | COVID-19 | Doxycycline | Health | National Institute for Health Research (NIHR) | Zithromax